{"id":"W2558389544","doi":"10.1016/j.ejca.2016.09.004","title":"ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer","year":2016,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Amgen","keywords":"Medicine; Placebo; Hazard ratio; Adverse effect; Internal medicine; Clinical endpoint; Surgery; Gastroenterology; Urology; Randomized controlled trial; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001013876,0.0003383193,0.0006536195,0.000137417,0.00007180015,0.00002906661,0.0003226105,0.00006931776,0.0003218257],"category_scores_gemma":[0.00006684389,0.0001809216,0.000118706,0.0003015897,0.0001149321,0.000022663,0.00008205359,0.000180882,0.000002160917],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002496516,"about_ca_system_score_gemma":0.000835554,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001457468,"about_ca_topic_score_gemma":0.002883875,"domain_scores_codex":[0.9971255,0.0005224046,0.001062165,0.0004106133,0.0004308799,0.0004484043],"domain_scores_gemma":[0.9978909,0.00006561613,0.0009814193,0.0003175007,0.000528261,0.0002162419],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7481511,0.000556638,0.0007016719,0.000028145,0.0008570373,0.0005874015,0.001923745,0.0005638795,0.1970783,0.000002353419,0.0005828828,0.04896684],"study_design_scores_gemma":[0.732818,0.02439321,0.01053251,0.00163228,0.000475572,0.0001256987,0.002869359,0.00002671725,0.203642,0.00000133118,0.02257646,0.0009068002],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996339,0.001700116,0.0002731065,0.0002435397,0.0003251792,0.0007492901,0.00006530954,0.000006242325,0.0002982719],"genre_scores_gemma":[0.9963667,0.001664139,0.00008451145,0.0001014292,0.0007630776,0.00006482767,0.000002967192,0.00007178442,0.000880559],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04806004,"threshold_uncertainty_score":0.7377768,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03384322118829779,"score_gpt":0.3135375361376028,"score_spread":0.279694314949305,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}